Side Effects of Ezetimibe
Ezetimibe is generally well-tolerated with an overall incidence of side effects similar to placebo, though specific adverse reactions warrant monitoring, particularly when combined with statins. 1
Common Side Effects
Ezetimibe Monotherapy
The most frequently reported adverse effects when ezetimibe is used alone include: 1
- Upper respiratory tract infection (most common) 2
- Joint pain (arthralgia) 2
- Pain in arms or legs 2
- Flu-like symptoms 2
- Diarrhea 2
- Inflammation of the sinuses (sinusitis) 2
- Fatigue/feeling tired 2
Combination Therapy with Statins
When ezetimibe is combined with statin therapy, the adverse effect profile shifts slightly: 1
- Nasopharyngitis/runny nose, sore throat 2
- Myalgia/muscle aches and pains 2
- Joint pain 2
- Flu-like symptoms 2
- Diarrhea 2
- Pain in arms or legs 2
- Upper respiratory tract infection 2
- Back pain 2
These adverse reactions are described as mild and transient, with the overall incidence remaining similar to placebo. 1
Serious Adverse Effects Requiring Monitoring
Hepatic Dysfunction
Increased liver enzymes can occur in patients taking ezetimibe alone or with statins, requiring baseline and periodic monitoring. 1
- Persistent elevations in hepatic transaminases may occur, particularly with concomitant statin therapy 1
- Your healthcare provider should perform blood tests to check liver function before and during treatment 2
- Treatment may need to be changed or stopped if liver enzyme elevations occur 2
- Ezetimibe is not recommended in patients with moderate to severe hepatic impairment 1
- Rare cases of severe cholestatic hepatitis and acute autoimmune hepatitis have been reported 3, 4
Myopathy and Rhabdomyolysis
Muscle problems, including muscle breakdown (rhabdomyolysis), can occur with ezetimibe, particularly when combined with statins or fibrates. 1
Patients should report immediately if they experience: 2
- Unexplained muscle pain, tenderness, or weakness
- Feeling more tired than usual
- Fever
- Muscle problems that persist even after stopping ezetimibe
The risk of muscle problems is higher when ezetimibe is combined with statins or fibrates. 2 Cases of myopathy have been reported both with ezetimibe monotherapy and in combination therapy. 5
Emerging Safety Signals
Recent pharmacovigilance data identified additional adverse reactions requiring attention: 6
- Unstable angina (strong signal detected)
- Crush syndrome/rhabdomyolysis (strong signal detected)
- Autoscopy (strong signal detected)
Contraindications and Special Populations
Absolute Contraindications
- History of hypersensitivity to ezetimibe 1
- Pregnancy and nursing: All lipid-lowering drugs, including ezetimibe, should be avoided during pregnancy and nursing or in women who may become pregnant 1
- No safety data exist in humans for use during pregnancy; avoid use 1
Drug Interactions Requiring Dose Adjustments
Monitor carefully when ezetimibe is used with: 1
- Cyclosporine (immunosuppressant)
- Fibrates (cholesterol-lowering medications)
- Bile acid sequestrants (take ezetimibe at least 2 hours before or 4 hours after bile acid sequestrants) 2
Clinical Context and Safety Profile
The overall safety profile of ezetimibe is favorable, with adverse effects being mild and transient in most cases. 1 The incidence of side effects is similar to placebo in controlled trials. 1 However, long-term safety data beyond 3 years require further investigation. 1
Ezetimibe has minimal impact on body weight and does not commonly cause muscle toxicity or hepatic dysfunction when used as monotherapy, though these risks increase when combined with statins. 1 Emotional stress may occur from adding new oral medication, particularly related to concerns about side effects. 1
Prompt withdrawal of ezetimibe is mandatory if significant liver test abnormalities develop during treatment. 4